Prof. Dr. Hamdi Levent Doğanay

1995–2001 Ege University Faculty of Medicine

2001–2006 Dokuz Eylül University Faculty of Medicine – Internal Medicine Specialization

2008–2011 Göztepe Training and Research Hospital – Gastroenterology Fellowship

2014 Ümraniye Training and Research Hospital – Associate Professorship in Gastroenterology

2021 University of Health Sciences – Professorship

Endoscopy

Colonoscopy

Biliary obstruction

Liver diseases

Chronic viral hepatitis

Fatty liver disease

Cancer

Hereditary cancer

Güzelbulut F, Gökçen P, Can G, Adalı G, Değirmenci Saltürk AG, Aslan E, Özdil K, Doğanay HL. Comparison of the Efficacy of Entecavir and Tenofovir in Reducing Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients: A Real-Life Study in Turkey. Turk J Gastroenterol. 2021;32(4):412–421. doi:10.5152/tjg.2021.20423.

Sayar S, Kürbüz K, Kahraman R, Öztürk O, Çalışkan Z, Doğanay HL, Özdil K. Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infection. Turk J Gastroenterol. 2020;31(7). doi:10.5152/tjg.2020.19295.

Gokcen P, Guzelbulut F, Adali G, Degirmenci Salturk AG, Ozturk O, Bahadir O, Kanatsiz E, Kiyak M, Ozdil K, Doganay HL. Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment. World J Gastroenterol. 2022;28(6). doi:10.3748/wjg.v28.i6.665.